Clinical Trial Update: Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of the triple therapy carbidopa/levodopa/entacapone in Parkinson's disease patients initiating levodopa therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Carbidopa/levodopa/entacapone (carbidopa; levodopa; entacapone)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2011-03-08